Two-year efficacy and safety of rapid smoking therapy in patients with cardiac and pulmonary disease.
D001348:Aversive Therapy / Q000379:methods*; D005260:Female; D006331:Heart Diseases / Q000150:complications*; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D012306:Risk; D000074606:Smoking Prevention